ACID-FAST BACILLI CONVERSION OF BEIJING AND NON-BEIJING STRAIN OF PULMONARY TUBERCULOSIS IN SOUTH SULAWESI
Downloads
Beijing strains are a major part of the Mycobacterium tuberculosis Asian phylogenetic lineage. Beijing strains represent about 50% of all TB strains in East Asia and at least 13% of strains worldwide. Beijing strain of Mycobacterium tuberculosis is presumed as the factor of the increase in bacteria virulence and drug resistance, and the contributor in treatment failure. The aim of this study was to analyze the association between acid-fast bacilli conversion with strain genotipe Beijing and non-Beijing of pulmonary tuberculosis in South Sulawesi. The design of research was observational analytic with prospective approach. The sampling technique used consecutive sampling. Data were taken from active pulmonary tuberculosis patients’ medical record in Balai Besar Kesehatan Paru Masyarakat Makassar (Pulmonary Health Center of Makassar) and Community Health Center in Gowa Regency, South Sulawesi from March to June 2018. Collected sputum samples were screened for AFB and identified as Beijing strain and non Beijing strains using Multiplex PCR in Tropical Disease Institute of Universitas Airlangga. The results is showed that the characteristics of the respondents consisted of 12 respondents (33.3%) aged 56-65 years, 25 respondents (69.4%) men and 28 respondents (77.8%) had low category gradation of AFB smear. Univariate analysis showed 6 respondents (16.7%) with Beijing strains, 30 respondents (83.3%) with non-Beijing strains, 32 respondents (88.9%) conversion sputum AFB and 4 respondents (11.1%) non conversion sputum AFB. Bivariate analysis with Chi-Square statistical test shows that p value 0.022 < 0,05, that means there was association of Beijing strains with BTA conversion. Microscopic examination of BTA can be used to monitor and evaluate the treatment of new pulmonary TB patients undergoing treatment and the Beijing Mycobacterium tuberculosis strain has a significant correlation with the treatment failure of anti-tuberculosis drugs in South Sulawesi.
World Health Organization (WHO), Bending the curve - ending TB: Annual report 2017, (World Health Organization, Regional Office for South-East Asia, 2017).
Viedma DG, Mokrousov, Rastogi N. Innovations in the molecular, Epidemiology of tuberculosis. Enfermedades Infecciosas Microbiologia Clinica 2010; 29:8-13.
Kementerian Kesehatan RI. Pedoman Nasional Penanggulangan Tuberkulosis, (Kementerian Kesehatan RI 2010, Jakarta: 20-21)
Aliyah Nur, Emmy H, Basti. Gambaran konversi sputum bakteri tahan Asam (BTA) dan Vitamin D pada penderita Tuberculosis Paru kasus baru. J Chest Crit and Emerg 2016; 3: 1-6.
Ryu Yon Ju, ‘Diagnosis of Pulmonary Tuberculosis: Recent Advances and Diagnostic Algorithms’, (2015) 78 Tuberculosis Respiratory Diseases. [64-71].
Wang X, Zhao L, Yu X, Li Y, Ma Y, Dong L, Huang H. Bead capture increases the sensitivity of sputum microscopy for the diagnosis of tuberculosis in Beijing, China. Transactions of the Royal Society of Tropical Medicine and Hygiene 2013:1-3.
Andrade Soraya, Gales Ana Cristina, Sader Helio Silva, Antimicrobial Resistance in Gram-Negative Bacteria from Developing Countries, (Spinger 2010)[249-266]
Parwati I, Reinout, Mirawati sudiro, Bachti alisjahbana. Mycobacterium tuberculosis population structures differ significantly on two Indonesian Island. Journal Of Clinical Microbiology 2008; 46:3639– 3645.
Supply Philip, Michael marceau, Sophie mangenot. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nature Genetics 2012; 45:172-180.
Borgdorff, Soolingen van. The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?. Clinical Microbiology and Infection 2013; 19: 889–901.
Couvin David, Nalin Rastogi. Tuberculosis-A global emergency: Tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage. Elseiver Tuberculosis 2015; 95:177-189.
Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG,Rusch-Gerdes S, Mokrousov I, Aleksic E, Allix-Beguec C, Antierens A, Augustynowicz-Kopec E, Ballif M, Barletta F, Beck HP, Barry CE, 3rd, Bonnet M, Borroni E, Campos- Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S, Hanekom M, Hoffner S, Jiao WW, Kalon S, Kohl TA, Kontsevaya I, Lillebaek T, Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng LH, Stakenas P, Toit K, Varaine F, Vukovic D. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet 2015;47: 242-249.
Thai Phan V K, Ha Dang T M, Hanh T Nguyen, Day Jeremy, Dunstan Sarah, Quynh Nguyen Thi, Kiet Vo Sy, Lan Nguyen Huu, Huy Dung Nguyen, Thi Ngoc Lan Nguyen. Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis. BMC Infectious Diseases 2018; 112:1-9.
Lisdawati Vivi, Puspandari Nelly, Parwati Ida. Studi pemetaan awal DNA Mycobacterium tuberculosis complex secara Spoligotyping pada hasil isolasi dahak pasien tuberkulosis paru dari 10 ibu kota propinsi. Buletin Penelititian Kesehatan 2010; 38:208 – 224.
Nakajima Chie, Tamaru Aki,Rahim Zeaur, Poudel Ajay,Maharjan Bhagwan, Saw Aye Khin, Ling Hong, Hattori Toshio, Iwamoto Tomotada, Fukushima Yukari, Haruka Suzuki, Yasuhiko Suzuki, Takashi Matsuba. Simple Multiplex PCR Assay for Identification of Beijing Family Mycobacterium tuberculosis Isolates with a Lineage-Specific Mutation in Rv0679c. Journal of Clinical Microbiology 2013; 5:2025–2032.
Dinas Kesehatan Provinsi Sulawesi selatan, Profil kesehatan sulawesi selatan tahun 2017 (Dinas Kesehatan Sulawesi Selatan 2017).
World Health Organization, Treatmen of tuberculosis guidelines fourth edition (World Health Organization 2010).
Global laboratory initiative, Laboratory diagnosis of tuberculosis by sputum microscopy (SA Phatology, 2013)
Oktavian Antonius, Chaidir Lidya, Krismawati Hana, Suebu Melda, Karapa Oktofianus. Distribusi genotipe mycobacterium tuberculosis dan transmisi tb di kota Jayapura provinsi Papua. Institute of Research and Development for Biomedicine Papua 2013: 70-85.
Garrido MS, Penna ML, Perez-Porcuna TM, Souza AB, Marreiro LS, Albuquerque BC, Martínez FE,. Factors associated with tuberculosis treatment default in an endemic area of the Brazilian Amazon: a case control-study. PLoS One 2012; 7:1-7.
Babalik A, Kilicaslan Z, Caner SS, Gungor G, Ortakoylu MG, Gencer S, McCurdy SA. A registry-based cohort study of pulmonary tuberculosis treatment outcomes in Istanbul, Turkey. Japan Journal Infectiuos Diseases 2013; 66: 115-120.
Babalik A, Kilicaslan Z, Kiziltas S, Gencer S, Ongen G. A retrospective case-control study, factors affecting treatment outcomes for pulmonary tuberculosis in Istanbul, Turkey. Balkan Medicine Journal 2013; 30: 204-210.
Sengul Aysun, Akturk Ulku, Aydemir Yusuf, Kaya Nurullah, Durmus Nagihan, Tasolar Fatma. Factors affecting successful treatment outcomes in pulmonary tuberculosis: a single-center experience in Turkey, 2005–2011. The journal of infection in developing countries 2015; 8: 821-828.
Feng JY, Su WJ, Tsai CC, Chang SC. Clinical impact of Mycobacterium tuberculosis W-Beijing genotype strain infection on
aged patients in Taiwan. J Clin Microbiol 2008; 46: 3127–3129. 25. Parwati I, Alisjahbana B, Apriani L, Rista D, Ottenhoff T, Zanden
A, Meer J. Mycobacterium tuberculosis Beijing Genotype Is an Independent Risk Factor for Tuberculosis Treatment. The lancet Infectious Diseases 2010; 10: 103-111.
Parwati ida, Reinout, Dick soolingen. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infection Diseases 2010; 10:103–111.
Hang Nguyen T.L, Maeda Shinji, Keicho Naoto, Pham H. Thuong, Hiroyoshi Endo. Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment. Tuberculosis 2015; 95: 336-342.
Konstantynovska Olha, Poteiko Petro, Synenko Tetiana, Kuznietsova Iryna, Rohozhyn Anton, Solodiankin Oleksii, Liashenko Oleksandr. Pulmonary tuberculosis among elderly and senile-aged patients depending
on Mycobacterium strains. European Respiratory Journal 2017; 50:2724.
Mourik Bas C, Knug J de Gerjo, Verbon Annelies, Mouton Johan, Bax Kannelore, Steenwinkel Jurriaaan. Assessment of Bactericidal Drug Activity and Treatment outcome in a mouse tuberculosis model using a clinical Beijing strain. American society for microbiology 2017; 61:1-9.
Anna Vyazovaya, Igor Mokrousov, Natalia Solovieva, Alexander Mushkin, Olga Manicheva, Boris Vishnevsky, Viacheslav Zhuravlev, Olga Narvskaya. Tuberculous spondylitis in Rhussia and prominent role of multidrug-resistant clone Mycobacterium tuberculosis Beijing B0/W148. American Society for Microbiology 2015: 1-14
Hu Y, Ma X, Graviss EA, Wang W, Jiang W, Xu B. A major subgroup of Beijing family Mycobacterium tuberculosis is associated with multidrug resistance and increased transmissibility. Epidemiol Infect
; 139: 130-138.
Rutaihwa Liliana K, Menardo Fabrizio, Stucki David, Sebastian M. Gygli, Serey D Ley, Malla Bijaya, Feldmann Julia, Borrell Farnov Sonia, Beisel Christian, Middelkoop Keren. Multiple Introductions of the Mycobacterium tuberculosis Lineage 2 Beijing into Africa over centuries. Cold spring harbor laboratory 2018; 1-21
Buu TN, Huyen MN, van Soolingen D, Lan NT, Quy HT, Tiemersma EW, et al. The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam. Clin Infect Dis 2010; 51: 879-886.
Copyright (c) 2019 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution — You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
